AZD8601 Study in CABG Patients

NCT03370887 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: AZD8601
DRUG: Placebo

Sponsor

AstraZeneca